Targeting of the tumor microcirculation by photodynamic therapy with a synthetic porphycene

Journal of Photochemistry and Photobiology B: Biology

Volumn 40, Issue 3, 1997, Pages 305-312

  Abels, C ^a,b   Szeimies, R M ^b   Steinbach, P ^b   Richert, C ^a   Goetz, A E ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Melanoma; Pharmacokinetics; Photosensitizer

Indexed keywords

LIPOSOME; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE;

AMELANOTIC MELANOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TARGETING; FLUORESCENCE; HAMSTER; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; LIGHT EXPOSURE; MALE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKINFOLD; SOLID TUMOR; SYNTHESIS; TISSUE DISTRIBUTION; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME;

ANIMALS; CRICETINAE; DISEASE MODELS, ANIMAL; MELANOMA, AMELANOTIC; MESOCRICETUS; MICROCIRCULATION; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NEOPLASM TRANSPLANTATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 0030669547     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(97)00074-2     Document Type: Article

References (45)

1. H. Ribbert, Über das Gefäß-System und die Heilbarkeit der Geschwülste, Dtsch. Med. Wochenschr., 30 (1904) 801-803.
2. P. Vaupal, F. Kallinowski and P. Okunieff, Blood flow, oxygen and nutrient supply and metabolic microenvironment of human tumors, Cancer Res., 49 (1989) 6449-6455.
3. J. Folkman and M. Klagsbrun, Angiogenic factors. Science, 235 (1987) 442-447.
4. R.D. Leek, A.L. Harris and C.E. Lewis, Cytokine networks in solid human tumors: regulation of angiogenesis, J. Leukoc. Biol., 56 (1994) 423-435.
5. J. Denekamp, Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy, Br. J. Radiol., 66 (1993) 181-196.
6. G. Gasparini And A.L. Harris, Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool, J. Clin. Oncol., 13 (1995) 765-782.
7. H. Pass, Photodynamic therapy in oncology: mechanism and clinical use, J. Natl. Cancer Inst., 85 (1993) 443-456.
8. M. Dellian, C. Abels, G.E.H. Kuhnle and A.E. Goetz, Effects of photodynamic therapy of leukocyte-endothelium interaction: differences between normal and tumour tissue, Br. J. Cancer, 72 (1995) 1125-1130.
9. W.M. Star, H.P. Marijnissen, A.E. Van Den Berg-Blok, J.A.C. Versteeg, K.A.P. Franken and H.S. Reinhold. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res., 46 (1986) 2532-2540.
10. T.J. Dougherty and S.L. Marcus, Photodynamic therapy, Eur. J. Cancer, 28A (1992) 1734-1742.
11. T.J. Dougherty, Studies on the structure of porphyrins contained in Photofrin II, Photochem. Photobiol., 46 (1987) 569-573.
12. T.J. Dougherty, M.T. Cooper and T.S. Mang, Cutaneous phototoxic occurences in patients receiving Photofrin, Lasers Surg. Med., 10 (1980) 485-488.
13. C. Richert, J.M. Wessels, M. Müller, M. Kisters, T. Benninghaus and A.E. Goetz, Photodynamic antitumor agents: β-methoxyethyl groups give access to functionalized porphycenes and enhance cellular uptake and activity, J. Med. Chem., 37 (1994) 2797-2807.
14. P.F. Aramendia, R.W. Redmond, S. Nonell, W. Schuster, S.E. Braslavsky, K. Schaffner and E. Vogel. The photophysical properties of porphycenes: potential photodynamic therapy agents, Photochem. Photobiol., 44 (1986) 555-559.
15. E. Vogel, M. Köcher, H. Schmickler and J. Lex, Porphycene - a novel porphin isomer, Angew. Chem. Int. Edit., 25 (1986) 257-259.
16. M. Guardiano, R. Biolo, G. Jori and K. Schaffner, Tetra-n-propylporphycene as a tumour localizer: pharmacokinetic and phototherapeutic studies in mice, Cancer Lett., 44 (1989) 1-6.
17. M. Dellian, C. Richert, F. Gamarra and A.E. Goetz, Photodynamic eradication of amelanotic melanoma of the hamster with fast acting photosensitizers. Int. J. Cancer, 65 (1996) 1-3.
18. M. Leunig, C. Richert, F. Gamarra, W. Lumper, E. Vogel, D. Jocham and A.E. Goetz, Tumor localisation kinetics of Photofrin and three synthetic porphyrinoids in an amelanotic melanoma of the hamster, Br. J. Cancer, 68 (1993) 225-234.
19. R.-M. Szeimies, S. Karrer, C. Abels, P. Steinbach, H. Messmann and M. Landthaler, 9-acetoxy-2,7-12,17-tetrakis-(β-methoxyethyl)-porphycene (ATMPn), a novel photoseusitizer for photodynamic therapy: Uptake kinetics and intracellular localization. J. Photochem. Photobiol. B: Biol., 34 (1996) 67-72.
20. J.G. Fortner, A.G. Mahy and G.R. Schrodt, Transplantable tumors of the Syrian (Golden) hamster. I. Tumors of the alimentary tract, endocrine glands and melanomas. Cancer Res., 21 (1961) 161-198.
21. B. Endrich, K. Asaishi, A.E. Goetz and K. Messmer, A new chamber technique for microvascular studies in unanesthetized hamsters, Res. Exp. Med., 177 (1980) 125-134.
22. K. Asaishi, B. Endrich, A.E. Goetz and K. Messmer, Quantitative analysis of microvascular structure and function in the amelanotic melanoma A-Mel-3. Cancer Res., 44 (1981) 1898-1904.
23. M. Dellian, S. Walenta, F. Gamarra, G.E.H. Kuhnle, W. Müller-Klieser and A.E. Goetz, High-energy shock waves enhance hyperthermic response of tumors: effects on blood flow, energy metabolism and tumor growth, J. Natl. Cancer Inst., 86 (1994) 287-293.
24. G.E.H. Kuhnle, M. Dellian, S. Walenta, W. Müller-Klieser and A.E. Goetz, Simultaneous high-resolution measurement of adenosine triphosphate levels and blood flow in the hamster amelanotic melanoma A-Mel-3, J. Natl. Cancer Inst., 84 (1992) 1642-1647.
25. C. Richert, Photosensibilisierung von neoplastischem Gewebe mit Porphycenen. Doctoral thesis, Ludwig-Maximilians-Universität, Munich, 1993.
26. C. Abels, P. Heil, M. Dellian, G.E.H. Kuhnle, R. Baumgartner and A.E. Goetz, In vivo fluorescence kinetics and spectra of 5-aminolevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster, Br. J. Cancer, 70 (1994) 826-833.
27. M. Leunig, A. Leunig, P. Lankes and A.E. Goetz, Evaluation of photodynamic therapy-induced heating of hamster melanoma and its effect on local tumour eradication, Int. J. Hyperthermia, 10 (1994) 297-306.
28. M.M. Tomayko and C.P. Reynolds, Determination of subcutaneous tumor size in athymic (nude) mice, Cancer Chemother. Pharmacol., 24 (1989) 148-154.
29. N. Weiss, M. Delius, S. Gambihler, P. Dirschedl, A.B. Goetz and W. Brendel, Influence of the shock wave application mode on the growth of A-Mel-3 and SSK2 tumors in vivo. Ultrasound Med. Biol., 16 (1991) 595-605.
30. R.B. Livingston and S.K. Carter, Experimental design and clinical trials: clinical perspectives, in: S.K. Carter, S.K. Glatstein, R.B. Livingston, (eds.), Principles of Cancer Treatment, McGraw-Hill, New York, 1982, pp. 34-45.
31. Q. Peng, J. Moan, G. Farrants, H.E. Danielsen and C. Rimington, Localization of potent photosensitizers in human tumor LOX by means of laser scanning microscopy. Cancer Lett., 53 (1990) 129-139.
32. K.S. Woodburn, N.J. Vardaxis, J.S. Hill, A.M. Kaye and D.R. Phillips, Evaluation of porphyrin characteristics required for photodynamic therapy, Photochem. Photobiol., 55 (1992) 697-704.
33. B. Endrich, F. Hammersen, A.E. Goetz and K. Messmer, Microcirculatory blood flow, capillary morphology and local oxygen pressure of the hamster amelanotic melanoma A-Mel-3, J. Natl. Cancer Inst., 68 (1982) 475-485.
34. T.F. Delaney, W.F. Sindelar, Z. Tochner, P.D. Smith, W.S. Friauf, G. Thomas, L. Dachowski, J.W. Cole, S.M. Steinberg and E. Glatstein, Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int. J. Radiat. Oncol. Biol. Phys., 25 (1993) 445-457.
35. W.F. Sindelar, T.F. Delaney, Z. Tochner, G. Thomas, L. Dachowski, P.D. Smith, W.S. Friauf, J.W. Cole and E. Glatstein, Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Arch. Surg., 126 (1991) 318-324.
36. D.A. Cortese (ed.), 5th International Photodynamic Association Biennial Meeting, Proc. SPIE 2371, 1995.
37. W. Bäumler, R.-M. Szeimies, C. Abels, S. Karrer and M. Landthaler, 9-acetoxy-2,7,12,17-tetrakis-(β-methoxyethyl) -porphycene (ATMPn), a novel photosensitizer for photodynamic therapy - dose dependent effects in vitro, in: Benjamin Ehrenberg, Giulio Jori, Johan Moan (eds.), Photochemotherapy: Photodynamic Therapy and Other Modalities, Proc. SPIE 2625, 1996, pp. 315-318.
38. S. Karrer, R.M. Szeimies, A. Ebert, S. Fickweiler, C. Abels, W. B̈umler, M. Landthaler, Dose-depedent photodynamic effects of 9-acetoxy-2,7,12,17-tetrakis-(β-methoxyetriyl-) porphycene in vitro, Lasers. Med Sci., in press.
39. C. Abels, G.E.H. Kuhnle and A.E. Goetz, Photodynamic diagnosis and therapy of tumors with 5-aminolevulinic acid (ALA)? - Kinetics and efficacy of ALA-induced porphyrins. Arch. Dermatol. Res., 287 (1995) 355.
40. L.R.C. Barclay, R.C. Cameron, B.J. Forrest, S.J. Locke, R. Nigam and M.R. Vinquist, Cholesterol: free radical peroxidation and transfer into phospholipid membranes, Biochim. Biophys. Acta, 1047 (1990) 255-263.
41. C. Riehen, A long-time-stable liposome formulation for porphyrinoid photosensitizers, J. Photochem. Photobiol. B: Biol., 19 (1993) 67-69.
42. J.M. Wessels and M. Nüsse, Possible use of porphycenes as a membrane marker for flow cytometric detection of micronuclei, Cytometry, S6 (1993) 55.
43. G. Jori, In vivo transport and pharmacokinetic behaviour of tumour photosensitizers, in: G. Bock, S. Harnett (eds.), Photosensitizing compounds: their chemistry, biology and clinical use, John Wiley, Chichester, 1989, pp. 78-94.
44. J.C. Maziere, P. Morliere and R. Santus, The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours. J. Photochem. Photobiol. B: Biol., 8 (1991) 351-360.
45. J.L. Goldstein and M.S. Brown, Binding and degradation of low density lipoproteins by cultured human fibroblasts, J. Biol. Chem., 249 (1974) 5153-5162.